PACTR201911857573624尚未招募未知
actoferrin versus iron polymaltose for the treatment of iron deficiency anemia in Egyptian children with cerebral palsy
Pediatrics Department Faculty of Medicine0 个研究点目标入组 70 人开始时间: 2019年9月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •Children with a formal diagnosis of cerebral palsy by a specialist in the management of children with cerebral palsy.
- •children with cerebral palsy diagnosed with iron deficiency anemia.
排除标准
- •Children who have received oral iron preparations over the previous 6 months.
- •Children having a medical or family history of beta thalassaemia or haemoglobinopathies.
- •Children who are currently suffering from an acquired acute infectious illness.
研究者
相似试验
尚未招募
4 期
Therapeutic Efficacy Of Artemether+Lumefantrine For The Treatment Of Uncomplicated Falciaprum Malaria In Papua New Guinea, 2017.MalariaACTRN12617000664347Department of Health88
已完成
4 期
Efficacy and safety of artemether+lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Afgoye site and Plasmodium vivax in Bosaso site, SomaliaInfection - Studies of infection and infectious agentsMalariaACTRN12618001224213World Health Organization Count Office Somalia85
已完成
4 期
Efficacy and safety of artemether+lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Jowhar and Bosaso sites, Somalia.MalariaACTRN12617001055392Ministry of Health and Human Services, Federal Government139
招募中
4 期
Ethiopia In-vivo Drug Efficacy Study 2023MalariaPACTR202311879488648Centers for Disease Control and Prevention528
已完成
不适用
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria, and chloroquine for P.vivax in Kyaing Tone (Eastern Shan State)Infection - Other infectious diseasesmalariaACTRN12610000881033Clinical Research Unit (Malaria), Ministry of Defense160